C84.4 类别:需要更具体的编码 Peripheral T-cell lymphoma, not elsewhere classified
ICD-10-CM C84.4 identifies “Peripheral T-cell lymphoma, not elsewhere classified” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 2: Neoplasms
编码说明
Inclusion terms3
- Lennert's lymphoma
- Lymphoepithelioid lymphoma
- Mature T-cell lymphoma, not elsewhere classified
上级编码说明
章节 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C84 · Mature T/NK-cell lymphomas
Excludes 11
personal history of non-Hodgkin lymphoma (Z85.72)
更具体的编码
C84.40Peripheral T-cell lymphoma, not elsewhere classified, unspecified site可计费的具体编码C84.41Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of head, face, and neck可计费的具体编码C84.42Peripheral T-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes可计费的具体编码C84.43Peripheral T-cell lymphoma, not elsewhere classified, intra-abdominal lymph nodes可计费的具体编码C84.44Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of axilla and upper limb可计费的具体编码C84.45Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of inguinal region and lower limb可计费的具体编码C84.46Peripheral T-cell lymphoma, not elsewhere classified, intrapelvic lymph nodes可计费的具体编码C84.47Peripheral T-cell lymphoma, not elsewhere classified, spleen可计费的具体编码C84.48Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites可计费的具体编码C84.49Peripheral T-cell lymphoma, not elsewhere classified, extranodal and solid organ sites可计费的具体编码C84.4APeripheral T-cell lymphoma, not elsewhere classified, in remission可计费的具体编码官方索引引用
官方索引引用 (4)
Lymphoma(of) (malignant) (4)
其他编码的引用 (2)
Excludes 1 · peripheral T-cell lymphoma, not elsewhere classified (C84.4-)
Excludes 1 · mature T-cell lymphoma, not elsewhere classified (C84.4-)
历史
编码历史
最近记录的变更 · FY2023
已变更无变更
FY2023
生效日期
- 名称变更
Peripheral T-cell lymphoma, not elsewhere classified
原名称: Peripheral T-cell lymphoma, not classified
类别 — 请选择更具体的编码
CDC/NCHS · FY2023所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 分类表无变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 分类表无变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 名称变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 分类表无变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
浏览此类别中更具体的编码。 参考核验不能确定临床适用性,也不保证报销。